Publications by authors named "Charles Schiffer"

100Publications

Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: when and for whom?

Haematologica 2020 Oct 9;Online ahead of print:2738-2745. Epub 2020 Oct 9.

Karmanos Cancer Institute, Wayne State University School of Medicine, Milwaukee, WI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2019.242891DOI Listing
October 2020

Distinctive phenotypes in two children with novel germline mutations - one with myeloid malignancy and increased fetal hemoglobin.

Pediatr Hematol Oncol 2020 Sep 29:1-15. Epub 2020 Sep 29.

Department of Pediatrics-Hematology/Oncology, Wayne State University-School of Medicine, Detroit, Michigan, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/08880018.2020.1814463DOI Listing
September 2020

Promoting Apoptosis with Venetoclax - A Benefit for Older Patients with AML.

N Engl J Med 2020 08;383(7):677-679

From the Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe2023326DOI Listing
August 2020

Infectious Complications of Tyrosine Kinase Inhibitors in Hematological Malignancies.

Infect Dis Clin North Am 2020 06;34(2):245-256

Department of Oncology, Wayne State University School of Medicine, Karmanos Cancer Institute, HWCRC - 4th Floor, 4100 John R, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.idc.2020.02.008DOI Listing
June 2020

In Reply.

Oncologist 2020 04 24;25(4):e744-e745. Epub 2019 Dec 24.

Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2019-0890DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160403PMC
April 2020

An Important Gap in Informed Consent Documents for Oncology Clinical Trials: Lack of Quantitative Details About Expected Treatment Outcomes.

JAMA Oncol 2019 Aug 22. Epub 2019 Aug 22.

Department of Oncology, Karmanos Cancer Institute, Wayne State University of Medicine, Detroit, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2019.3146DOI Listing
August 2019

Discontinuation of tyrosine kinase inhibitors in patients with chronic myelogeneous leukemia - You can do this at home if you read the instructions.

Haematologica 2019 Aug;104(8):1508-1511

Joseph Dresner Chair for Hematologic Malignancies, Departments of Oncology and Medicine, Wayne State University School of Medicine, Karmanos Cancer Institute, Detroit, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2019.222216DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669156PMC
August 2019

The spectrum of musculoskeletal symptoms in patients with chronic myeloid leukemia after stopping tyrosine kinase inhibitors.

Leuk Res 2019 04 11;79:1-2. Epub 2019 Feb 11.

Department of Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2019.02.001DOI Listing
April 2019

Real-world testing and treatment patterns in chronic lymphocytic leukemia: A SEER patterns of care analysis.

Cancer 2019 01 21;125(1):135-143. Epub 2018 Oct 21.

Division of Hematology/Oncology, Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.31738
Publisher Site
http://dx.doi.org/10.1002/cncr.31738DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309467PMC
January 2019

The evolution of dasatinib dosage over the years and its relevance to other anticancer medications.

Cancer 2018 07 3;124(13):2687-2689. Epub 2018 May 3.

Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31516DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6860021PMC
July 2018

"Epigenetic" modification as therapy for acute myeloid leukemia.

Cancer 2018 01 6;124(2):242-244. Epub 2017 Dec 6.

Multidisciplinary Leukemia/Lymphoma Group, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31137DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6871512PMC
January 2018

Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.

J Clin Oncol 2018 01 28;36(3):283-299. Epub 2017 Nov 28.

Charles A. Schiffer, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI; Kari Bohlke, American Society of Clinical Oncology, Alexandria, VA; Meghan Delaney, Children's National Medical System & George Washington University, Washington DC; Heather Hume, CHU Sainte-Justine, University of Montreal, Montreal, Quebec, Canada; Anthony J. Magdalinski, Alliance Cancer Specialists, Sellersville, PA; Jeffrey J. McCullough, University of Minnesota, Minneapolis, MN; James L. Omel, Patient Representative, Grand Island, NE; John M. Rainey, University Health Center, Lafayette, LA; Paolo Rebulla, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Scott D. Rowley, Hackensack University Medical Center, Hackensack, NJ; Michael B. Troner, Miami Cancer Institute, Miami, FL; and Kenneth C. Anderson, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.1734DOI Listing
January 2018

Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Summary.

J Oncol Pract 2018 02 28;14(2):129-133. Epub 2017 Nov 28.

Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI; American Society of Clinical Oncology, Alexandria, VA; and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JOP.2017.028902
Publisher Site
http://dx.doi.org/10.1200/JOP.2017.028902DOI Listing
February 2018

Challenges in the Clinical Application of the American Society of Clinical Oncology Value Framework: A Medicare Cost-Benefit Analysis in Chronic Lymphocytic Leukemia.

J Oncol Pract 2017 12 16;13(12):e1002-e1011. Epub 2017 Nov 16.

Karmanos Cancer Institute/Wayne State University, Detroit, MI; and The University of Chicago, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2017.024778DOI Listing
December 2017

Transplantation for Myeloma - Now or Later?

N Engl J Med 2017 04;376(14):1378-1379

From the Division of Hematology-Oncology, Department of Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe1700453DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6860019PMC
April 2017

Point: Standard vs Investigational Agents as Upfront Treatment for High-Risk AML.

Oncology (Williston Park) 2017 Mar;31(3):190-1

View Article

Download full-text PDF

Source
March 2017

Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States.

J Natl Cancer Inst 2016 Jul 4;108(7). Epub 2016 Mar 4.

Affiliations of authors:Department of Health Policy and Management, Johns Hopkins University , Baltimore, MD (WVP); Department of Medicine (RAL) and Departments of Pediatrics and of Public Health Sciences (RMC), University of Chicago, Chicago, IL; Eshelman School of Pharmacy and Gillings School of Global Public Health, Lineberger Comprehensive Cancer Center , and Cecil G. Sheps Center for Health Services Research, University of North Carolina , Chapel Hill, NC (SBD); Department of Haematology, Hammersmith Hospital, Imperial College , London , UK (JFA); Department of Medicine (RH, SS) and Department of Hematology and Oncology (MCM), University of Heidelberg, Mannheim, Germany; Department of Haematology and Oncology, S. Orsola-Malpighi University Hospital (MB), and Department of Hematology, "L. e A. Seragnoli" (GM), University of Bologna , Bologna , Italy ; Department of Haematology and Oncology, University Hospital , Jena , Germany (EE); INSERM Centre d'Investigation Clinique (CIC) 1402, CHU de Poitiers, Poitiers, France (JG, FG); Laboratoire d'Hematologie, Universite Victor Segalen, Bordeaux, Pessac, France (FXM); Department of Internal Medicine, Hematology and Oncology, University Hospital Brno , Brno , Czech Republic (JM); Department of Hematology and Oncology, University Hospital Leipzig , Leipzig , Germany (DN); Barbara Ann Karmanos Cancer Institute, Wayne State University , Detroit, MI (CAS); Department of Medicine, Weill Cornell Medical Center , New York, NY (RTS); Uppsala University , Uppsala , Sweden (BS).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948567PMC
July 2016

The artful management of older patients with acute myeloid leukemia.

Expert Rev Hematol 2016 May 2;9(5):425-32. Epub 2016 Mar 2.

a Division of Hematology/Oncology, Department of Oncology , Barbara Ann Karmanos Cancer Center and Wayne State University School of Medicine , Detroit , MI 48201 , USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/17474086.2016.11
Publisher Site
http://dx.doi.org/10.1586/17474086.2016.1153963DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876746PMC
May 2016

Bronchoscopy can be done safely in patients with thrombocytopenia.

Transfusion 2016 Feb 7;56(2):344-8. Epub 2015 Oct 7.

Division of Hematology and Medical Oncology, Karmanos Cancer Institute.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.13348DOI Listing
February 2016

Pattern of Duplicate Presentations at National Hematology-Oncology Meetings: Influence of the Pharmaceutical Industry.

J Oncol Pract 2016 Mar 8;12(3):254-9, 252-3. Epub 2015 Sep 8.

Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2015.004523DOI Listing
March 2016

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.

Authors:
Ayalew Tefferi Hagop Kantarjian S Vincent Rajkumar Lawrence H Baker Jan L Abkowitz John W Adamson Ranjana Hira Advani James Allison Karen H Antman Robert C Bast John M Bennett Edward J Benz Nancy Berliner Joseph Bertino Ravi Bhatia Smita Bhatia Deepa Bhojwani Charles D Blanke Clara D Bloomfield Linda Bosserman Hal E Broxmeyer John C Byrd Fernando Cabanillas George Peter Canellos Bruce A Chabner Asher Chanan-Khan Bruce Cheson Bayard Clarkson Susan L Cohn Gerardo Colon-Otero Jorge Cortes Steven Coutre Massimo Cristofanilli Walter J Curran George Q Daley Daniel J DeAngelo H Joachim Deeg Lawrence H Einhorn Harry P Erba Francisco J Esteva Elihu Estey Isaiah J Fidler James Foran Stephen Forman Emil Freireich Charles Fuchs James N George Morie A Gertz Sergio Giralt Harvey Golomb Peter Greenberg Jordan Gutterman Robert I Handin Samuel Hellman Paulo Marcelo Hoff Ronald Hoffman Waun Ki Hong Mary Horowitz Gabriel N Hortobagyi Clifford Hudis Jean Pierre Issa Bruce Evan Johnson Philip W Kantoff Kenneth Kaushansky David Khayat Fadlo R Khuri Thomas J Kipps Margaret Kripke Robert A Kyle Richard A Larson Theodore S Lawrence Ross Levine Michael P Link Scott M Lippman Sagar Lonial Gary H Lyman Maurie Markman John Mendelsohn Neal J Meropol Yoav Messinger Therese M Mulvey Susan O'Brien Roman Perez-Soler Raphael Pollock Josef Prchal Oliver Press Jerald Radich Kanti Rai Saul A Rosenberg Jacob M Rowe Hope Rugo Carolyn D Runowicz Brenda M Sandmaier Alan Saven Andrew I Schafer Charles Schiffer Mikkael A Sekeres Richard T Silver Lillian L Siu David P Steensma F Marc Stewart Wendy Stock Richard Stone Rainer Storb Louise C Strong Martin S Tallman Michael Thompson Naoto T Ueno Richard A Van Etten Julie M Vose Peter H Wiernik Eric P Winer Anas Younes Andrew D Zelenetz Charles A LeMaistre

Mayo Clin Proc 2015 Aug 23;90(8):996-1000. Epub 2015 Jul 23.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2015.06.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365030PMC
August 2015

Optimal dose and schedule of consolidation in AML: is there a standard?

Best Pract Res Clin Haematol 2014 Sep-Dec;27(3-4):259-64. Epub 2014 Oct 15.

Division of Hematology/Oncology, Department of Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, HWCRC-4th Floor, 4100 John R, Detroit, MI 48201, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2014.10.007DOI Listing
July 2015

They took a mulligan and mostly got it right … the issue of prophylactic platelet transfusion for patients receiving autologous stem cell transplantation.

Transfusion 2014 Oct;54(10):2372-4

Department of Oncology, Wayne State University School of Medicine, Karmanos Cancer Institute, Detroit, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.12821DOI Listing
October 2014

First-line treatment for patients with CML in chronic phase: why imatinib is an appropriate choice.

Oncology (Williston Park) 2013 Aug;27(8):780, 825

Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan, USA.

View Article

Download full-text PDF

Source
August 2013

Haematological cancer: Prophylactic platelet transfusion is frequently not necessary.

Nat Rev Clin Oncol 2013 Aug 2;10(8):431-2. Epub 2013 Jul 2.

Division of Hematology/Oncology, Karmanos Cancer Institute, HWCRC-4th Floor, 4100 John R. Street, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2013.113DOI Listing
August 2013

If at first you don't succeed: stem-cell transplantation for acute myeloid leukemia after first relapse.

J Clin Oncol 2013 Apr 25;31(10):1259-61. Epub 2013 Feb 25.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.43.4241DOI Listing
April 2013

Acute myeloid leukaemia in adults.

Lancet 2013 Feb;381(9865):484-95

Division of Haematology and Stem Cell Transplantation Unit, Naples, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(12)61727-9DOI Listing
February 2013

Which TKI should be recommended as initial treatment for CML in chronic phase?

Oncology (Williston Park) 2012 Oct;26(10):912, 914

Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan, USA.

View Article

Download full-text PDF

Source
October 2012

Genetic biomarkers in acute myeloid leukemia: will the promise of improving treatment outcomes be realized?

Expert Rev Hematol 2012 Aug;5(4):395-407

Department of Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/ehm.12.32DOI Listing
August 2012

Gemtuzumab ozogamicin: time to resurrect?

J Clin Oncol 2012 Nov 17;30(32):3921-3. Epub 2012 Sep 17.

Department of Leukemia, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 428, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.43.0132DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874205PMC
November 2012

Adherence to hepatitis B screening and prophylactic lamivudine for prevention of rituximab-associated hepatitis B reactivation.

J Oncol Pharm Pract 2013 Mar 25;19(1):18-23. Epub 2012 May 25.

Department of Pharmacy, Karmanos Cancer Center, Detroit, MI 48098, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155212447975DOI Listing
March 2013

Therapy-related myeloid leukemia after treatment for epithelial ovarian carcinoma: an epidemiological analysis.

Gynecol Oncol 2011 Dec 19;123(3):456-60. Epub 2011 Aug 19.

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Wayne State University, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2011.07.097DOI Listing
December 2011

Hematologic malignancies: where do we stand in 2011?

J Clin Oncol 2011 Feb 10;29(5):473-4. Epub 2011 Jan 10.

University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.33.8897DOI Listing
February 2011

CML: how low can you go?

Blood 2010 Nov;116(19):3686-7

Wayne State University School of Medicine, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-08-302323DOI Listing
November 2010

Thrombocytopenia and platelet transfusions in patients with cancer.

Cancer Treat Res 2011 ;157:251-65

Division of Hematology/Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4419-7073-2_15DOI Listing
February 2011

Very late recurrences of leukemia: why does leukemia awake after many years of dormancy?

Leuk Res 2011 Feb;35(2):139-44

Division of Hematology and Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2010.09.016DOI Listing
February 2011

Molecular monitoring of BCR-ABL transcripts in patients with chronic myelogenous leukemia: is high sensitivity of clinical value?

Curr Hematol Malig Rep 2010 Apr;5(2):88-94

Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-010-0046-xDOI Listing
April 2010

"I am older, not elderly," said the patient with acute myeloid leukemia.

J Clin Oncol 2010 Feb 21;28(4):521-3. Epub 2009 Dec 21.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.25.8616DOI Listing
February 2010

Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia.

Biologics 2009 13;3:205-14. Epub 2009 Jul 13.

Division of Hematology/Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2726068PMC
February 2010

Molecular characterization of AML: a significant advance or just another prognostic factor?

Best Pract Res Clin Haematol 2008 Dec;21(4):621-8

Division of Hematology/Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, 4100 John R, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2008.08.006DOI Listing
December 2008

Zinc toxicity from massive and prolonged coin ingestion in an adult.

Am J Med Sci 2008 Nov;336(5):430-3

Division of Gastroenterology, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S000296291532150
Publisher Site
http://dx.doi.org/10.1097/MAJ.0b013e31815f2c05DOI Listing
November 2008

Concurrent B-cell chronic lymphocytic leukemia and multiple myeloma treated successfully with lenalidomide.

Leuk Res 2009 Apr 3;33(4):561-4. Epub 2008 Aug 3.

Division of Hematology/Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, HWCRB-4th Floor, 4100 John R, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2008.06.024DOI Listing
April 2009

Current treatment options and strategies for myelodysplastic syndromes.

Expert Opin Pharmacother 2008 Jul;9(10):1667-78

Wayne State University School of Medicine, Karmanos Cancer Institute, Division of Hematology/Oncology, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.9.10.1667DOI Listing
July 2008

Monitoring minimal residual disease in patients with chronic myeloid leukemia after treatment with tyrosine kinase inhibitors.

Curr Opin Hematol 2008 Mar;15(2):134-9

Division of Hematology/Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0b013e3282f42898DOI Listing
March 2008

World Health Organization and international prognostic scoring system: the limitations of current classification systems in assessing prognosis and determining appropriate therapy in myelodysplastic syndromes.

Semin Hematol 2008 Jan;45(1):3-7

Division of Hematology/Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2007.10.002DOI Listing
January 2008

Monitoring the response and course of chronic myeloid leukemia in the modern era of BCR-ABL tyrosine kinase inhibitors: practical advice on the use and interpretation of monitoring methods.

Blood 2008 Feb 30;111(4):1774-80. Epub 2007 Nov 30.

Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-09-110189DOI Listing
February 2008

Advances in MDS.

Clin Adv Hematol Oncol 2007 Jun;5(6):450-2

Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Mich., USA.

View Article

Download full-text PDF

Source
June 2007

BCR-ABL tyrosine kinase inhibitors for chronic myelogenous leukemia.

N Engl J Med 2007 Jul;357(3):258-65

Division of Hematology/Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMct071828DOI Listing
July 2007

Myelodysplasia: the good, the fair and the ugly.

Best Pract Res Clin Haematol 2007 Mar;20(1):49-55

Karmanos Cancer Institute, Wayne State University School of Medicine, 4100 John R. Street, 4HW-CRC, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2006.12.001DOI Listing
March 2007

Clinical issues in the management of patients with myelodysplasia.

Hematology Am Soc Hematol Educ Program 2006 :205-10

Barbara Ann Karmanos Cancer Institute, Wayne State University (SOM), 4100 John R. Street, 4HW-CRC, Detroit MI 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2006.1.205DOI Listing
June 2007

Granulocyte transfusion therapy 2006: The comeback kid?

Med Mycol 2006 Sep;44(Supplement_1):S383-S386

Division of Hematology/Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Michigan, Detroit, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13693780600752499DOI Listing
September 2006

Update on practical aspects of the treatment of chronic myeloid leukemia with imatinib mesylate.

Curr Hematol Malig Rep 2006 Sep;1(3):141-51

Division of Hematology/Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, 4100 John R., Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-996-0002-yDOI Listing
September 2006

Fifty years of clinical research by the leukemia committee of the cancer and leukemia group B.

Clin Cancer Res 2006 Jun;12(11 Pt 2):3556s-63s

Department of Medicine and Cancer Research Center, University of Chicago, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-9001DOI Listing
June 2006

Granulocyte transfusion.

Curr Opin Hematol 2006 Jan;13(1):45-9

Divison of Hematology/Oncology, Karmanos Cancer Institute, Detroit, Michigan 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.moh.0000190114.38650.b2DOI Listing
January 2006

"3+7" therapy for the treatment of acute myeloid leukemia. PRO.

Clin Adv Hematol Oncol 2005 Feb;3(2):127-9

Karmanos cancer Institute, Wayne State University School of Medicine, USA.

View Article

Download full-text PDF

Source
February 2005

"Acute myelogenous leukemia like" translocations in CML blast crisis: two new cases of inv(16)/t(16;16) and a review of the literature.

Leuk Res 2006 Feb 1;30(2):225-32. Epub 2005 Aug 1.

Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Internal Medicine, Division of Hematology-Oncology, Karmanos Cancer Institute, 4HW-4238, 4100 John R, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2005.06.008DOI Listing
February 2006

Use of myeloid growth factors for patients with febrile neutropenia: plus ca change, plus c'est la même chose.

Pediatr Blood Cancer 2005 Sep;45(3):242-3

Division of Hematology/Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, 4100 John R, HWCRC 4th Floor, Detroit, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.20449DOI Listing
September 2005

A single dose of rasburicase is sufficient for the treatment of hyperuricemia in patients receiving chemotherapy.

Leuk Res 2005 Apr 8;29(4):463-5. Epub 2004 Dec 8.

Department of Pharmacy, Karmanos Cancer Institute/Harper University Hospital, Detroit Medical Center, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2004.09.004DOI Listing
April 2005

Marrow failure.

Hematology Am Soc Hematol Educ Program 2004 :318-36

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2004.1.318DOI Listing
April 2005

Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia.

Blood 2004 Jun 19;103(11):4036-42. Epub 2004 Feb 19.

Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Department of Hematology and Medical Oncology, The Cleveland Clinic Foundation, Desk R35, 9500 Euclid Ave, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2003-09-3118DOI Listing
June 2004

Hematopoietic growth factors and the future of therapeutic research on acute myeloid leukemia.

N Engl J Med 2003 Aug;349(8):727-9

Division of Hematology-Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMp030076DOI Listing
August 2003

Practical aspects of the treatment of chronic myelogenous leukemia with imatinib mesylate.

Curr Hematol Rep 2003 Jan;2(1):57-64

Division of Hematology/Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Harper Hospital, 4 Brush South, 3990 John R, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
January 2003

Strategies for managing refractoriness to platelet transfusions.

Curr Hematol Rep 2003 Mar;2(2):158-64

Department of Pathology, Harper University Hospital, 3990 John R, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
March 2003

The effect of imatinib mesylate on patients with Philadelphia chromosome-positive chronic myeloid leukemia with secondary chromosomal aberrations.

Clin Cancer Res 2003 Apr;9(4):1333-7

Department of Pathology and the Division of Hematology/Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.

View Article

Download full-text PDF

Source
April 2003

Management of patients refractory to platelet transfusion.

Arch Pathol Lab Med 2003 Apr;127(4):409-14

University of Cincinnati Medical Center, Hoxworth Blood Center, Cincinnati, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1043/0003-9985(2003)127<0409:MOPRTP>2.0.CO;2DOI Listing
April 2003